Sunovion Pharmaceuticals of Marlborough has begun inpatient recruitment for a clinical trial to test proprietary cell therapy that could benefit stroke victims.
RXi Pharmaceuticals Corporation announced this week a phase 2 clinical trial to evaluate the safety and clinical activity of Samcyprone, an immunomodulator that could help clear cutaneous warts.
Manufacturing and technology are strongholds in the Central Massachusetts economy, and business leaders continue to underscore the importance of supporting the sectors, which have significant crossover.
U.S. veterans with spinal cord injuries will now have access to ReWalk Robotics' exoskeleton systems, following a decision by the U.S. Department of Veterans Affairs.
Marlborough-based Boston Scientific has issued a global recall on its Chariot Guiding Sheath following 14 complaints of failure, including while the device was inside patients, which could lead to obstruction of blood flow causing stroke or kidney damage.
In a move that the Baker-Polito administration says will result in more jobs, $8.9 million has been distributed to 87 companies and training organizations around the state to help train more than 7,500 workers, with Worcester organizations receiving roughly $650,000 in training funds.
Fostering a business-friendly atmosphere takes a village, but leading the charge in Marlborough are two key players: Mayor Arthur Vigeant and Susanne Morreale Leeber, president and CEO of the Marlborough Regional Chamber of Commerce.
Marlborough environmental testing firm Accutest Laboratories of New England has been fined $100,000 for allegedly not complying with a 2014 court judgement that included $1.75 million in fines for alleged environmental violations.